Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Extrawell Pharmaceutical Holdings Limited (HK:0858)

:0858

0858

Extrawell Pharmaceutical Holdings Limited

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Extrawell Pharmaceutical Holdings Limited (0858) Ratios

Compare

0 Followers

Extrawell Pharmaceutical Holdings Limited Ratios

HK:0858's free cash flow for Q2 2024 was HK$0.38. For the 2024 fiscal year, HK:0858's free cash flow was decreased by HK$ and operating cash flow was HK$-0.10. See a summary of the company’s cash flow.

Ratios	TTM	Mar 24	Mar 23	Mar 22	Mar 21
Liquidity Ratios
Current Ratio	18.71	3.13	3.03	3.65	3.58
Quick Ratio	18.65	3.06	2.84	3.50	3.44
Cash Ratio	1.88	2.14	2.09	2.56	2.54
Solvency Ratio	1.01	0.21	0.21	-0.18	0.14
Operating Cash Flow Ratio	0.06	0.06	-0.02	>-0.01	-0.18
Short-Term Operating Cash Flow Coverage	0.00	-0.14	0.07	0.01	0.57
Net Current Asset Value	HK$ 751.84M	HK$ -492.62M	HK$ -465.15M	HK$ -431.27M	HK$ -424.44M
Leverage Ratios
Debt-to-Assets Ratio	0.09	0.43	0.45	0.50	0.46
Debt-to-Equity Ratio	0.11	0.80	0.91	1.13	0.92
Debt-to-Capital Ratio	0.10	0.44	0.48	0.53	0.48
Long-Term Debt-to-Capital Ratio	0.09	0.44	0.48	0.53	0.48
Financial Leverage Ratio	1.15	1.88	2.02	2.25	2.01
Debt Service Coverage Ratio	-0.13	-21.67	-14.62	11.06	-11.66
Interest Coverage Ratio	-0.66	-0.71	-1.40	-0.62	-1.75
Debt to Market Cap	0.64	3.67	2.75	1.51	2.57
Interest Debt Per Share	0.06	0.26	0.26	0.25	0.25
Net Debt to EBITDA	57.35	3.10	2.94	-4.49	4.24
Profitability Margins
Gross Profit Margin	43.01%	42.91%	50.80%	54.02%	55.32%
EBIT Margin	-10.48%	201.90%	196.90%	-137.59%	122.24%
EBITDA Margin	1.05%	219.15%	213.52%	-123.70%	130.36%
Operating Profit Margin	-10.81%	-15.37%	-24.97%	-8.86%	-21.05%
Pretax Profit Margin	300.15%	185.66%	183.95%	-148.20%	110.19%
Net Profit Margin	294.08%	178.11%	176.65%	-153.67%	107.34%
Continuous Operations Profit Margin	296.92%	178.81%	177.33%	-151.85%	110.31%
Net Income Per EBT	97.98%	95.93%	96.03%	103.69%	97.41%
EBT Per EBIT	-2777.82%	-1208.09%	-736.72%	1671.93%	-523.42%
Return on Assets (ROA)	12.56%	8.95%	9.91%	-10.40%	6.58%
Return on Equity (ROE)	15.08%	16.80%	19.99%	-23.37%	13.22%
Return on Capital Employed (ROCE)	-0.48%	-0.80%	-1.47%	-0.63%	-1.35%
Return on Invested Capital (ROIC)	-0.47%	-0.81%	-1.49%	-0.67%	-1.37%
Return on Tangible Assets	12.57%	8.97%	9.94%	-10.43%	6.60%
Earnings Yield	87.52%	80.73%	62.80%	-32.48%	38.72%
Efficiency Ratios
Receivables Turnover	8.09	12.52	9.46	8.63	7.40
Payables Turnover	6.89	6.25	5.63	5.41	5.56
Inventory Turnover	13.06	10.56	2.88	4.41	4.09
Fixed Asset Turnover	0.47	0.53	0.50	0.55	0.55
Asset Turnover	0.04	0.05	0.06	0.07	0.06
Working Capital Turnover Ratio	0.12	0.58	0.52	0.52	0.55
Cash Conversion Cycle	20.09	5.28	100.56	57.62	72.92
Days of Sales Outstanding	45.09	29.15	38.58	42.29	49.32
Days of Inventory Outstanding	27.95	34.57	126.78	82.74	89.28
Days of Payables Outstanding	52.95	58.44	64.79	67.41	65.69
Operating Cycle	73.04	63.72	165.35	125.03	138.60
Cash Flow Ratios
Operating Cash Flow Per Share	<0.01	<0.01	>-0.01	>-0.01	>-0.01
Free Cash Flow Per Share	<0.01	>-0.01	>-0.01	>-0.01	>-0.01
CapEx Per Share	<0.01	<0.01	<0.01	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	0.57	-1.06	7.02	4.11	1.02
Dividend Paid and CapEx Coverage Ratio	2.34	0.49	-0.17	-0.32	-63.32
Capital Expenditure Coverage Ratio	2.34	0.49	-0.17	-0.32	-63.32
Operating Cash Flow Coverage Ratio	0.02	<0.01	>-0.01	>-0.01	-0.02
Operating Cash Flow to Sales Ratio	0.05	0.04	-0.02	>-0.01	-0.13
Free Cash Flow Yield	0.80%	-2.13%	-5.40%	-0.26%	-4.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	1.14	1.24	1.59	-3.08	2.58
Price-to-Sales (P/S) Ratio	3.36	2.21	2.81	4.73	2.77
Price-to-Book (P/B) Ratio	0.17	0.21	0.32	0.72	0.34
Price-to-Free Cash Flow (P/FCF) Ratio	124.85	-47.06	-18.52	-391.23	-20.64
Price-to-Operating Cash Flow Ratio	71.44	49.82	-130.04	-1.61K	-20.97
Price-to-Earnings Growth (PEG) Ratio	<0.01	-1.35	>-0.01	0.01	0.03
Price-to-Fair Value	0.17	0.21	0.32	0.72	0.34
Enterprise Value Multiple	376.53	4.11	4.26	-8.32	6.37
Enterprise Value	236.84M	653.51M	671.98M	810.67M	644.07M
EV to EBITDA	376.53	4.11	4.26	-8.32	6.37
EV to Sales	3.96	9.00	9.09	10.29	8.30
EV to Free Cash Flow	147.29	-192.04	-59.85	-850.66	-61.81
EV to Operating Cash Flow	84.28	203.33	-420.25	-3.49K	-62.79
Tangible Book Value Per Share	0.51	0.32	0.27	0.22	0.26
Shareholders’ Equity Per Share	0.51	0.32	0.27	0.22	0.26
Tax and Other Ratios
Effective Tax Rate	0.01	<0.01	<0.01	-0.04	>-0.01
Revenue Per Share	0.02	0.03	0.03	0.03	0.03
Net Income Per Share	0.07	0.05	0.05	-0.05	0.03
Tax Burden	0.98	0.96	0.96	1.04	0.97
Interest Burden	-28.64	0.92	0.93	1.08	0.90
Research & Development to Revenue	<0.01	0.01	<0.01	0.00	0.00
SG&A to Revenue	0.35	0.35	0.33	0.30	0.34
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	0.02	0.02	-0.01	<0.01	-0.12

Currency in HKD

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing